In vivo Tracking of Human Neural Stem Cells Following Transplantation into a Rodent Model of Ischemic Stroke by 신동아
International Journal of Stem Cells Vol. 5, No. 1, 2012
ORIGINAL ARTICLE
79
Accepted for publication February 20, 2012
Correspondence to Jihwan Song
CHA Stem Cell Institute, Department of Biomedical Science, CHA 
University, 606-16 Yeoksam 1-dong, Gangnam-gu, Seoul 135-081, 
Korea
Tel: +82-2-3468-3393, Fax: +82-2-538-4102
E-mail: jsong@cha.ac.kr
*These authors contributed equally to this work.
In vivo Tracking of Human Neural Stem Cells Following 
Transplantation into a Rodent Model of Ischemic Stroke
Da-Jeong Chang1*, Hyeyoung Moon2*, Yong Hyun Lee1, Nayeon Lee1, 
Hong J. Lee3, Iksoo Jeon1, Hyunseung Lee2, Tae-Sun Hwang1, Seung-Hun Oh1, 
Dong Ah Shin4, Seung U. Kim3, Kwan Soo Hong2, Jihwan Song1
1CHA Stem Cell Institute, Department of Biomedical Science, CHA University, Seoul, 
2Division of Magnetic Resonance, Korea Basic Science Institute, Ochang, 
3Medical Research Institute, Chung-Ang University College of Medicine, 
4Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea
Background and Objectives: Ischemic stroke caused by middle cerebral artery occlusion (MCAo) is the major type 
of stroke, but there are currently very limited options for cure. It has been shown that neural stem cells (NSCs) or 
neural precursor cells (NPCs) can survive and improve neurological deficits when they are engrafted in animal models 
of various neurological diseases. However, how the transplanted NSCs or NPCs are act in vivo in the injured or diseased 
brain is largely unknown. In this study, we utilized magnetic resonance imaging (MRI) techniques in order to under-
stand the fates of human NSCs (HB1.F3) following transplantation into a rodent model of MCAo.
Methods and Results: HB1.F3 human NSCs were pre-labeled with ferumoxides (Feridex®)-protamine sulfate complexes, 
which were visualized and examined by MRI up to 9 weeks after transplantation. Migration of the transplanted cells 
to the infarct area was further confirmed by histological methods. 
Conclusions: Based on these observations, we speculate that the transplanted NSCs have the extensive migratory ability 
to the injured site, which will in turn contribute to functional recovery in stroke. 
Keywords: Human neural stem cells (hNSCs), Ischemic stroke, Middle cerebral artery occlusion (MCAo), Magnetic resonance 
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Introduction
  Stroke is one of the leading causes of adult death and 
disability worldwide. Ischemic stroke is caused by blockade 
of the blood supply to part of the brain. Despite numerous 
research efforts, there are still currently very limited ther-
apeutic options for the stroke-damaged patients. It has 
been shown that neural stem cells (NSCs) or neural pre-
cursor cells (NPCs) engrafted in animal models of various 
neurological diseases can survive and improve neurological 
deficits (1, 2). We have previously established a clonal hu-
man neural stem cell line, HB1.F3 (briefly called F3 there-
after), which was immortalized by a retroviral vector en-
coding v-myc oncogene (3, 4). The F3 cells showed a multi-
potent capacity to differentiate into neurons and glial cells 
(3, 4) and were able to ameliorate the neurological deficits 
in animal models of stroke (5-8). However, compared with 
these differentiation and therapeutic potentials, how the 
transplanted NSCs act in order to exert such effects in vivo 
is largely unknown. In this regard, it is worthwhile to uti-
lize magnetic resonance imaging (MRI) approaches to 
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Fig. 1. Detection of the Feridex®-labeled hNSCs using 4.7T animal 
MRI. F3 hNSCs were transplanted into the ipsilateral side of MCAo 
animal models, and their migration patterns were monitored up to 
9 weeks using T2*-weighted MR images. (A) Coronal views taken 
at the injected zone in the striatum. (B) Coronal views taken at the 
accumulated zone. (C) Sagittal view, showing the migration and ac-
cumulation of transplanted hNSC in the posterior region.
non-invasively monitor cells that are labeled with MR con-
trast agent, which has been one of the major research di-
rections in the past decade (9-13). In particular, the ability 
to image animals repeatedly using MRI can serve as useful 
tools to monitor the presence, migration and distribution 
patterns of transplanted cells in vivo. In this study, we em-
ployed a 4.7 T animal MRI to follow up the fates of F3 
human NSC labeled with ferumoxides (Feridex®)-prot-
amine sulfate complexes following transplantation into a 
rodent model of middle cerebral artery occlusion (MCAo) 
up to 9 weeks. Interestingly, we found that the majority 
of transplanted cells were migrated to the infarct area, 
showing a patho-tropism. In this study, we also described 
the detailed migration patterns of transplanted hNSCs. 
Materials and Methods
MCAo animal models 
  All of the experimental animals were manipulated in ac-
cordance with the CHA University IACUC (Institutional 
Animal Care and Use Committee; IACUC090012). Adult 
male Sprague-Dawley rats (n=8) weighing 250∼300 g 
(Orient, Seoul, Korea) were used in this experiment. After 
anesthesia with 1% ketamine (30 mg/kg, i.p) and xylazine 
hydrochloride (4 mg/kg, i.p), body temperature of rats were 
maintained at 37±1oC by a rectal probe and heating pad. 
According to the method of Longa, animals were subjected 
to temporary middle cerebral artery occlusion (MCAo), 
which was induced by the retrograde insertion of a 3-0 
poly-L-lysine-coated nylon suture via the external carotid ar-
tery into the internal carotid artery and MCA. Reperfusion 
carried out by removing the suture 60 min later (14).
Preparation of F3 hNSCs for transplantation
  For cell labeling, ferumoxide and protamine sulfate 
were initially prepared at a concentration of 2 μg/ml of 
DMEM each without serum, which were subsequently 
mixed for 30 min at room temperature and were added 
with an equal volume to the culture medium containing 
F3 hNSCs (13). Cells were cultured with the mixture for 
12∼16 hr at 37oC. At 7 days after the induction of MCAo, 
cells were stereotaxically transplanted into the striatum 
(n=4) using the following conditions: 1×105 cells in 2 μl 
(AP: ＋1.0 mm, ML: −1.5 mm, DV: −4.0 mm). As con-
trols (n=4), a vehicle containing medium was trans-
planted into the same coordinates. Transplanted animals 
were received cyclosporine A (Sigma, 10 mg/kg, i.p) 24 h 
before transplantation and daily up to 9 weeks.　　
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Fig. 2. Histological analyses of Feridex®-labeled hNSCs. (A∼F) Prussian blue staining showing the presence and distribution of Feridex®-
labeled hNSCs. Left panel, lower magnification; A∼F, high magnification. (G) Distribution patterns of Feridex®-labled hNSC, showing the 
great majority of transplanted cells were localized at the periphery of infarct region. (H, I) Coronal views of T2 and T2*-weighted images,
providing the gross morphology of infarct area and the location of transplanted cells, respectively. (J) Immunohistochemical staining showing
the presence of human cells. Scale bars: left panel, 1 mm; A~F, 100 μm, J, 20 μm.
MRI detection of transplanted cells
  To detect the Feridex®-labeled F3 hNSCs, we employed 
a 4.7T Bio Spec (Bruker, Germany) for animal MRI analy-
sis using T2- and T2*-weighted imaging techniques. The MRI 
setting and detection methods were the same as described 
previously (13). To detect the transplanted stem cells, 
Prussian blue staining was carried out at 9 weeks follow-
ing transplantation as described (13), followed by im-
munohistochemical staining using an antibody against hu-
man specific-nuclei (Chemicon, 1：500). 
Results
Detection and migration of the Feridex®-labeled 
hNSCs using MRI
  To investigate the migratory effects of NSC, we trans-
planted Feridex®-labeled hNSC into the ipsilateral side of 
MCAo animal models, and followed their migration pat-
terns up to 9 weeks using MRI. Fig. 1A and 1B show the 
representative coronal views of T2*-weighted MR images 
taken from 9 weeks following transplantation. Interesting-
ly, cells transplanted into the striatum (Fig. 1A) were also 
detected and accumulated in the posterior region (Fig. 
1B). Fig. 1C is the sagittal view of T2*-weighted images, 
showing the migration and accumulation of transplanted 
hNSC in the posterior region. Taken together, these coro-
nal and sagittal views of T2*-weighted MR images clearly 
show that the transplanted hNSCs migrated to the infarct 
region in anterior-posterior and dorsal-ventral directions. 
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Migration patterns of Feridex®-labeled hNSCs
  In addition to MRI analysis, we carried out histological 
examinations at 9 weeks in order to understand the migra-
tion patterns of transplanted hNSCs to the infarcted area. 
Fig. 2 shows the results of Prussian blue staining (left 
panel, lower magnification; Fig. 2A-F, high magnifica-
tion). Fig. 2G shows the distribution patterns of Feridex®- 
labled hNSC, indicating the great majority of transplanted 
cells were localized at the periphery of infarct region. Fig. 
2H and 2I show coronal view of T2 and T2*-weighted im-
ages, providing the gross morphology of infarct area and 
the location of transplanted cells, respectively. Fig. 2J 
shows that the Feridex®-containing cells (i.e., MRI-pos-
itive cells) were indeed derived from human NSCs, judged 
by the positive staining for an antibody against hu-
man-specific nuclei. Taken together, these results clearly 
indicate the transplanted hNSC migrated to the periphery 
of infarct region in a ventro-posterior direction. 
Discussion
  Over the past several years, there has been the great in-
terest in the potential of stem cells for treating stroke, and 
studies from animal experiments and clinical trials using 
various cell types in recent years strongly suggest that 
stem cell therapy would be one of the legitimate options 
for the treatment of stroke (15-17). In this study, we 
showed that the fates of transplanted F3 hNSCs in a ro-
dent model of ischemic stroke can be efficiently monitored 
by using an animal MRI. We found that the Feridex®-la-
beled hNSCs can survive up to 9 weeks after trans-
plantation and were migrated to the infarct region, of 
which results were further confirmed by histological meth-
ods using Prussian blue staining, as well as immunohisto-
chemical staining using a human-specific antibody. Accor-
ding to our observations, there is a strong tendency of trans-
planted hNSCs to migrate to the infarct area, showing a 
strong patho-tropism, which has been also observed in ani-
mal models of various other diseases, including brain 
tumors. Several studies have reported that neural stem 
cells or neural precursor cells express the chemokine re-
ceptor, CXCR4, which has the high affinity to SDF-1 
(stromal cell-derived factor-1) that is strongly released in 
the ischemic boundary zone of the brain (18, 19).
  Previous studies using F3 hNSCs indicate that they can 
differentiate into neurons and astrocytes and possess elec-
trophysiological characteristics of mature neurons (20). It 
is also known that F3 hNSCs can secrete some neuro-
trophic factors (4). Therefore, it is quite likely that all of 
these properties will contribute to the neural protection 
and/or neuronal regeneration of the ischemic tissues, as 
well as to the amelioration of behavioral deficits in stroke 
animal models. Therefore, in order to develop efficient 
stroke cell therapy, it will be essential to determine the 
optimal cell types and transplantation conditions. 
  Taken together, the present MRI study provides useful 
information on the migratory routes of hNSCs following 
transplantation into a rodent model of ischemic stroke. 
Therefore, in combination with behavioral tests, in vivo 
tracking method using MRI will provide useful tools to 
closely monitor the action mode of transplanted stem cells 
and the extent of functional recovery following stem cell 
transplantation non-invasively.
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